Amgen To Webcast Investor Meeting At Upcoming American Heart Association
Scientific Sessions 2013
THOUSAND OAKS, Calif., Nov. 14, 2013
THOUSAND OAKS, Calif., Nov. 14, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will
host a webcast investor meeting at the American Heart Association (AHA)
Scientific Sessions 2013 on Tuesday, Nov. 19, at 7 p.m. CST. Sean E. Harper,
M.D., executive vice president of Research and Development at Amgen, along
with members of Amgen's clinical development team and clinical investigators,
will participate at the investor meeting to discuss data being presented at
Live audio of the investor meeting will be simultaneously broadcast over the
Internet and will be available to members of the news media, investors and the
The webcast, as with other selected presentations regarding developments in
Amgen's business given by management at certain investor and medical
conferences, can be found on Amgen's website, www.amgen.com, under Investors.
Information regarding presentation times, webcast availability and webcast
links are noted on Amgen's Investor Relations Events Calendar. The webcast
will be archived and available for replay for at least 90 days after the
Amgen is committed to unlocking the potential of biology for patients
suffering from serious illnesses by discovering, developing, manufacturing and
delivering innovative human therapeutics. This approach begins by using tools
like advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics
manufacturing expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer since 1980,
Amgen has grown to be the world's largest independent biotechnology company,
has reached millions of patients around the world and is developing a pipeline
of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on
CONTACT: Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Arvind Sood, 805-447-1060 (investors)
Press spacebar to pause and continue. Press esc to stop.